Reviewing GoodRx (NASDAQ:GDRX) & Nutex Health (NASDAQ:NUTX)

Nutex Health (NASDAQ:NUTX) and GoodRx (NASDAQ:GDRX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, dividends, profitability and analyst recommendations.

Profitability

This table compares Nutex Health and GoodRx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nutex Health	7.34%	17.67%	7.37%
GoodRx	3.82%	9.31%	4.38%

Institutional and Insider Ownership

5.3% of Nutex Health shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 44.7% of Nutex Health shares are owned by insiders. Comparatively, 4.2% of GoodRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Nutex Health and GoodRx”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutex Health	$875.26 million	0.79	$70.79 million	$8.98	11.08
GoodRx	$796.85 million	0.88	$30.44 million	$0.09	22.67

Nutex Health has higher revenue and earnings than GoodRx. Nutex Health is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Nutex Health has a beta of 0.03, suggesting that its share price is 97% less volatile than the S&P 500. Comparatively, GoodRx has a beta of 1.52, suggesting that its share price is 52% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Nutex Health and GoodRx, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutex Health	0	1	2	0	2.67
GoodRx	3	8	5	0	2.13

Nutex Health presently has a consensus price target of $252.50, indicating a potential upside of 153.79%. GoodRx has a consensus price target of $3.98, indicating a potential upside of 95.14%. Given Nutex Health’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Nutex Health is more favorable than GoodRx.

Summary

Nutex Health beats GoodRx on 9 of the 14 factors compared between the two stocks.

About Nutex Health

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

About GoodRx

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.